Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Oxcarbazepine NDC 50268-679 by Avpak, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

50 - 679 15

50 - 679 15

This is a description of a medication called Oxcarbazepine. It comes in the form of tablets, which are only available through prescription. The tablets come in a unit dose of 50 (5x10). The details of the medication such as quantity, instructions, etc., are not given clearly. The text also contains some random characters and codes, and therefore, the information provided is not very useful.*

50 - 680 15

50 - 680 15

This is a description for Oxcarbazepine tablets, USP which come in 300mg tablets. This drug is available only via prescription with a quantity of 50 tablets in a package containing 5 unit dose packets of 10 tablets each. It has National Drug Code (NDC) 50268.680-15 and the LT code 0268 68015. The text contains information regarding its origin (PAHACT D e Mot i prvided s o.), manufacturer's packaging (Comgespocage s st 2G50 6 b 7 st 1500 DT GFin 157 on U5 ol o), and mentions of OFPEAGH OF CALEREL and Venstcarsd o. The last line is not readable.*

50 - 681 15

50 - 681 15

This is a medication called Oxcarbazepine in tablet form that is only available with a prescription. The packaging contains 50 tablets with 5 or 10 in each unit dose. There is a product identification number of 5026868115 and a website mentioned that may or may not relate to the product (PAHACIST Dot, Maicaten Gs). Other text is not readable.*

oxcarbazepinetabfig1 - oxcarbazepinetabfig1

oxcarbazepinetabfig1 - oxcarbazepinetabfig1

The log-rank test was performed with a resulting p-value of 0.0001. The text also includes a table showing time on trial from Day 2 to Day 11 for each treatment group. The treatment group is Oxcarbarspine.*

oxcarbazepinetabfig2 - oxcarbazepinetabfig2

oxcarbazepinetabfig2 - oxcarbazepinetabfig2

oxcarbazepinetabfig3 - oxcarbazepinetabfig3

oxcarbazepinetabfig3 - oxcarbazepinetabfig3

This appears to be the results of a log-rank test, with a p-value of 0.0001. There is also a chart with numbers ranging from 10 to 130 and a treatment group labeled as "HIGH-LOW" with a measure of "Time to exit (days)".*

oxcarbazepinetabfig4 - oxcarbazepinetabfig4

oxcarbazepinetabfig4 - oxcarbazepinetabfig4

The text represents statistical analysis results of a medical treatment. Specifically, it indicates the p-value of a log-rank test and a graph presenting the time to exit in days for two different treatment groups labeled as "HIGH" and "LOW". However, the quality is not high making it difficult to confirm the context with certainty.*

oxcarbazepinetabstruct - oxcarbazepinetabstruct

oxcarbazepinetabstruct - oxcarbazepinetabstruct

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.